7 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... - IDSA Guidelines ... #Tuberculosis ... #medications #pharmacology ... #IDSA #Guidelines
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Adjuvant therapies ... in critical care ... meningitis - Tuberculous ... mechanical ventilation, ARDS ... InfectiousDiseases #Infections #Pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Resistant Tuberculosis ... MultiDrugResistant #Tuberculosis ... #pharmacology # ... dosing #idsa #drugs
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... recommendations on drugs ... in a treatment regimen ... antimicrobials #pharmacology ... #ebm #idsa
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... Disease in HIV-AIDS ... RAL-based ART regimen ... HIV-infected persons with clinical ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... Cryptococcosis in HIV-AIDS ... as substantial clinical ... #Cryptococcus #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Complex in HIV-AIDS ... disease based on clinical ... AviumComplex #MAC #IDSA ... infections #HIVAIDS #pharmacology